| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 7, Issue 8 1039-1050, Copyright © 1996 by American Association of Cancer Research
ARTICLES |
M Tiainen, D Pajalunga, F Ferrantelli, S Soddu, G Salvatori, A Sacchi and M Crescenzi
Molecular Oncogenesis Laboratory Regina Elena Cancer Center, Rome, Italy.
Terminally differentiated cells are specialized cells unable to proliferate that constitute most of the mammalian body. Despite their abundance, little information exists on the characteristics of cell cycle control in these cells and the molecular mechanisms that prevent their proliferation. They are generally believed to be irreversibly restricted to the G0 state. In this report, we define some features of a paradigmatic terminally differentiated system, the skeletal muscle, by studying its responses to various mitogenic stimuli. We show that forced expression of a number of cell cycle-regulatory genes, including erbB-2, v-ras, v-myc, B-myb, ld-1, and E2F-1, alone or in combinations, cannot induce terminally differentiated skeletal muscle cells (myotubes) to synthesize DNA. However, serum-stimulated myotubes display a typical immediate-early response, including the up-regulation of c-fos, c-jun, c-myc, and ld-1. They also elevate the expression of cyclin D1 after 4 hours of serum treatment. All these events take place in myotubes in a way that is indistinguishable from that of quiescent, undifferentiated myoblasts reactivated by serum. Moreover, pretreatment with serum shortens the time required by E1A to induce DNA synthesis, confirming that myotubes can partially traverse G1. Serum growth factors do not activate late-G1 genes in myotubes, suggesting that the block that prevents terminally differentiated cells from proliferating acts in mid-G1. Our results show that terminally differentiated cells are not confined to G0 but can partially reenter G1 in response to growth factors; they contribute to a much-needed definition of terminal differentiation. The important differences in the control of the cell cycle between terminally differentiated and senescent cells are discussed.
This article has been cited by other articles:
![]() |
L. Narciso, P. Fortini, D. Pajalunga, A. Franchitto, P. Liu, P. Degan, M. Frechet, B. Demple, M. Crescenzi, and E. Dogliotti Terminally differentiated muscle cells are defective in base excision DNA repair and hypersensitive to oxygen injury PNAS, October 23, 2007; 104(43): 17010 - 17015. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pajalunga, A. Mazzola, A. M. Salzano, M. G. Biferi, G. De Luca, and M. Crescenzi Critical requirement for cell cycle inhibitors in sustaining nonproliferative states J. Cell Biol., March 12, 2007; 176(6): 807 - 818. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Camarda, F. Siepi, D. Pajalunga, C. Bernardini, R. Rossi, A. Montecucco, E. Meccia, and M. Crescenzi A pRb-independent mechanism preserves the postmitotic state in terminally differentiated skeletal muscle cells J. Cell Biol., November 8, 2004; 167(3): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Huh, M. H. Parker, A. Scime, R. Parks, and M. A. Rudnicki Rb is required for progression through myogenic differentiation but not maintenance of terminal differentiation J. Cell Biol., September 13, 2004; 166(6): 865 - 876. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Gurtner, I. Manni, P. Fuschi, R. Mantovani, F. Guadagni, A. Sacchi, and G. Piaggio Requirement for Down-Regulation of the CCAAT-binding Activity of the NF-Y Transcription Factor during Skeletal Muscle Differentiation Mol. Biol. Cell, July 1, 2003; 14(7): 2706 - 2715. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. M. Bonapace, L. Latella, R. Papait, F. Nicassio, A. Sacco, M. Muto, M. Crescenzi, and P. P. Di Fiore Np95 is regulated by E1A during mitotic reactivation of terminally differentiated cells and is essential for S phase entry J. Cell Biol., June 10, 2002; 157(6): 909 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Latella, A. Sacco, D. Pajalunga, M. Tiainen, D. Macera, M. D'Angelo, A. Felici, A. Sacchi, and M. Crescenzi Reconstitution of Cyclin D1-Associated Kinase Activity Drives Terminally Differentiated Cells into the Cell Cycle Mol. Cell. Biol., August 15, 2001; 21(16): 5631 - 5643. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Mal, D. Chattopadhyay, M. K. Ghosh, R. Y.C. Poon, T. Hunter, and M. L. Harter p21 and Retinoblastoma Protein Control the Absence of DNA Replication in Terminally Differentiated Muscle Cells J. Cell Biol., April 17, 2000; 149(2): 281 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Li, R. A. Poolman, and G. Brooks Role of G1 phase cyclins and cyclin-dependent kinases during cardiomyocyte hypertrophic growth in rats Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H814 - H822. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |